絞り込み

17396

広告

日本人も「大きな一歩」を 月面着陸へ日米協力 (毎日新聞)

萩生田光一文部科学相と米航空宇宙局(NASA)のジム・ブライデンスタイン長官は10日、オンラインで会談し、米国の有人月面探査計画の日米協力に関する共同宣言に署名...

  1. 腸内ウイルス、治療に一役 酵素が腸炎菌を...
  2. ヒト受精卵使うゲノム編集了承 厚労省と文...
  3. コロナ後遺症、厚労省調査へ (毎日新聞)...
  4. 新型コロナ アビガン有効性結論出ず 藤田...

ニュース一覧

Adverse reaction profiles of hemorrhagic adverse reactions caused by direct oral anticoagulants analyzed using the Food and Drug Administration Adverse Event Reporting System (FAERS) database and the Japanese Adverse Drug Event Report (JADER) database.

著者 Shimada K , Hasegawa S , Nakao S , Mukai R , Sasaoka S , Ueda N , Kato Y , Abe J , Mori T , Yoshimura T , Kinosada Y , Nakamura M
Int J Med Sci.2019 ; 16(9):1295-1303.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (54view , 0users)

Full Text Sources

Direct oral anticoagulants (DOACs) are used in anticoagulant therapy. The purpose of this study was to evaluate the association of DOAC-induced gastrointestinal (GI) and nervous system hemorrhage using the FDA's Adverse Event Reporting System (FAERS) database and the Japanese Adverse Drug Event Report (JADER) database. We identified and analyzed the reports of hemorrhagic reactions between 2004 and 2016 from the FAERS and JADER databases, and calculated the adjusted reported odds ratio (ROR) using the multiple logistic regression method. Additionally, we used the time-to-onset analysis. In the FAERS database, the adjusted ROR of apixaban, rivaroxaban, and dabigatran for GI hemorrhage was 6.79 (5.84-7.91), 19.58 (18.85-20.34), and 14.51 (13.58-15.51), respectively. In the JADER database, the adjusted ROR of apixaban, rivaroxaban, edoxaban, and dabigatran for GI hemorrhage was 11.80 (9.50-14.64), 11.03 (9.18-13.26), 10.17 (6.95-14.88), and 9.85 (7.23-13.42), respectively. We found that the association of GI hemorrhage with DOACs was affected by sex (female). Additionally, 30% of GI hemorrhage was observed after 30 days. Hemorrhagic reactions of both GI and nervous systems were observed in both the spontaneous reporting system databases. We recommend that female patients who experience symptoms related to GI hemorrhage should be closely monitored and advised to adhere to an appropriate care plan. Additionally, our results show that patients should be closely monitored for hemorrhage even after a month.
PMID: 31588196 [PubMed - in process]
印刷用ページを開く Endnote用テキストダウンロード